Page last updated: 2024-11-03

risperidone and Adult Refsum Disease

risperidone has been researched along with Adult Refsum Disease in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
"Infantile Refsum disease (IRD) appears with varying degrees of impaired vision, hearing loss, developmental delays, and neuromotor deficiencies."1.31Infantile refsum disease in four Amish sibs. ( Bader, PI; Cangany, N; Dougherty, S; Jackson, CE; Raymond, G, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bader, PI1
Dougherty, S1
Cangany, N1
Raymond, G1
Jackson, CE1

Other Studies

1 other study available for risperidone and Adult Refsum Disease

ArticleYear
Infantile refsum disease in four Amish sibs.
    American journal of medical genetics, 2000, Jan-17, Volume: 90, Issue:2

    Topics: Adolescent; Antidepressive Agents; Child; Consanguinity; Female; Fluoxetine; Humans; Lorazepam; Male

2000